AHR and cancer: L-Kyn appears to function as an oncometabolite as cancer cells exhibit increased Trp uptake and metabolism, resulting in elevated L-Kyn levels that activate the transcription factor aryl hydrocarbon receptor (AHR), promoting cancer cell growth [16].